Form 4 holding
Chief Operating Officer
RedHill Biopharma Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 176,910,000
- Estimated value
- Report date
- 01 Oct 2026
- Price
- Ownership
- Direct
Gilead Raday - Chief Operating Officer at RedHill Biopharma Ltd.
Issuer-level insider activity
- Role
- Chief Operating Officer
- Issuer ticker
- RDHL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Gilead Raday since 15 Nov 2025
Reported holdings for Gilead Raday in RedHill Biopharma Ltd.
Form 4 holding
Chief Operating Officer
RedHill Biopharma Ltd.
- Security class
- American Depository Shares
- Shares / value
- 131,690,000
- Estimated value
- Report date
- 01 Oct 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
Chief Operating Officer
RedHill Biopharma Ltd.
- Security class
- American Depositary Shares
- Shares / value
- 104,130,000
- Estimated value
- Report date
- 10 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Gilead Raday in RedHill Biopharma Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.